Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (101-110 of 294) with videos related to

Pageof 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma disseminationMélanie Juilland, Nagham Alouche, Ivana Ubezzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screenLloyd T Lam, R Eric Davis, Vu N Ngo, et al.
Leukemia|March 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trialMichael Oertel, Marita Ziepert, Fabian Frontzek, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and CytopathologyEvgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2020
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center AnalysisPatrick Stelmach, Klaus Wethmar, Christoph Groth, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case SeriesGöran Ramin Boeckel, Silke Dorothea Hölscher, Christin Bürger, et al.
Cancers|December 9, 2023
Involved-Site Radiation Therapy Enables Effective Disease Control in Parenchymal Low-Grade Primary Cerebral LymphomaNiklas Benedikt Pepper, Michael Oertel, Gabriele Reinartz, et al.
Leukemia|November 17, 2021
Publisher Correction: Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphomaKatrin Reutter, Sarah Sandmann, Jonas Rohde, et al.
Pageof 30

Showing results (101-110 of 294) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma disseminationMélanie Juilland, Nagham Alouche, Ivana Ubezzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screenLloyd T Lam, R Eric Davis, Vu N Ngo, et al.
Leukemia|March 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trialMichael Oertel, Marita Ziepert, Fabian Frontzek, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and CytopathologyEvgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2020
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center AnalysisPatrick Stelmach, Klaus Wethmar, Christoph Groth, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case SeriesGöran Ramin Boeckel, Silke Dorothea Hölscher, Christin Bürger, et al.
Cancers|December 9, 2023
Involved-Site Radiation Therapy Enables Effective Disease Control in Parenchymal Low-Grade Primary Cerebral LymphomaNiklas Benedikt Pepper, Michael Oertel, Gabriele Reinartz, et al.
Leukemia|November 17, 2021
Publisher Correction: Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphomaKatrin Reutter, Sarah Sandmann, Jonas Rohde, et al.
Pageof 30